advisorsecurities master

ANIKAnika Therapeutics Inc

CSNasdaq (XNAS)·USD

Identity

Security key
11736
Ticker
ANIK
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
1993-05-03
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
ANIK

Detail

Enriched 2026-08-14 20:47

Market cap
$294,826,740.98
Shares outstanding (class)
13,382,966
Shares outstanding (weighted)
13,382,966
SIC
3841 SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Employees
235
Location
BEDFORD, MA
Description

Anika Therapeutics Inc operates in the OA Pain Management and regenerative solutions space, focusing on early intervention orthopedics. The company leverages proprietary hyaluronic acid (HA) technology to develop differentiated products and provides products and services. Its OA Pain Management products include Orthovisc, Monovisc, and Cingal. Monovisc and Orthovisc are single- and multi-injection HA viscosupplement products indicated for pain relief from OA conditions and are generally administered to patients in an office setting. In the United States, Monovisc and Orthovisc are marketed exclusively by Johnson & Johnson MedTech. It generates maximum revenue from the OEM Channel and derives the majority of its revenue from the United States, with a presence in Europe and other countries.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data